News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,951 Results
Type
Article (39193)
Company Profile (283)
Press Release (648475)
Section
Business (203911)
Career Advice (1996)
Deals (35375)
Drug Delivery (89)
Drug Development (80863)
Employer Resources (168)
FDA (16099)
Job Trends (14808)
News (344666)
Policy (32451)
Tag
Academia (2530)
Alliances (49184)
Alzheimer's disease (1257)
Approvals (16050)
Artificial intelligence (147)
Bankruptcy (352)
Best Places to Work (11581)
Biotechnology (200)
Breast cancer (188)
Cancer (1365)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64703)
Collaboration (482)
Compensation (260)
COVID-19 (2542)
C-suite (108)
Data (1390)
Diabetes (172)
Diagnostics (6170)
Earnings (84898)
Employer resources (146)
Events (110007)
Executive appointments (394)
FDA (16768)
Funding (426)
Gene therapy (195)
GLP-1 (597)
Government (4334)
Healthcare (18694)
Infectious disease (2634)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16339)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7861)
Lung cancer (197)
Lymphoma (98)
Manufacturing (206)
Medical device (13211)
Medtech (13216)
Mergers & acquisitions (19196)
Metabolic disorders (452)
Neuroscience (1577)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1693)
Obesity (258)
Opinion (185)
Patents (117)
People (56459)
Phase I (20122)
Phase II (28496)
Phase III (21245)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5890)
Regulatory (21665)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1460)
Startups (3562)
United States (15141)
Vaccines (563)
Weight loss (181)
Date
Today (2)
Last 7 days (580)
Last 30 days (2334)
Last 365 days (35181)
2024 (35006)
2023 (40083)
2022 (51175)
2021 (55711)
2020 (54088)
2019 (46544)
2018 (35019)
2017 (32126)
2016 (31488)
2015 (37555)
2014 (31318)
2013 (26345)
2012 (28571)
2011 (29263)
2010 (27329)
Location
Africa (713)
Arizona (195)
Asia (37267)
Australia (6087)
California (3809)
Canada (1449)
China (304)
Colorado (171)
Connecticut (176)
Europe (79831)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (224)
Maryland (626)
Massachusetts (2959)
Michigan (172)
Minnesota (290)
New Jersey (1100)
New York (1080)
North Carolina (742)
Northern California (1693)
Ohio (146)
Pennsylvania (923)
South America (1091)
Southern California (1460)
Texas (547)
Utah (108)
Washington State (399)
687,951 Results for "exelixis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May 2024
Exelixis, Inc. announced that members of the company’s management team will participate in fireside chats at the following investor conferences in May.
May 7, 2024
·
2 min read
Press Releases
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December 2024
November 27, 2024
·
1 min read
Policy
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
Exelixis, Inc. (Nasdaq: EXEL) today announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla).
May 20, 2024
·
3 min read
Press Releases
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in November
November 7, 2024
·
1 min read
Biotech Bay
Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in a fireside chat at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4 at 4:20 p.m. ET / 3:20 p.m. CT / 1:20 p.m. PT in Chicago.
May 28, 2024
·
1 min read
Business
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2024 financial results will be released on Tuesday, April 30, 2024 after the markets close.
April 16, 2024
·
1 min read
Business
Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2024, provided an update on progress toward achieving key corporate objectives, and detailed its recent and anticipated commercial, clinical and pipeline development milestones.
April 30, 2024
·
21 min read
Press Releases
Exelixis Announces Third Quarter 2024 Financial Results and Provides Corporate Update
October 29, 2024
·
20 min read
Press Releases
Exelixis Announces Update on Second Patent Litigation Trial with MSN Laboratories
October 15, 2024
·
4 min read
Press Releases
Sairopa reports research milestones achieved in partnership with Exelixis, totalling $35 Million from consecutive clinical milestone payments in 2024
December 18, 2024
·
3 min read
1 of 68,796
Next
